● Recruiting

A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1)

Condition: Solid Tumors · Neoplasms · Sponsor: GlaxoSmithKline

PhasePhase 1

Planned participants675

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

The goal of this study is to assess the safety and tolerability of Mocertatug Rezetecan . The study will also see how the levels of Mo-Rez change over time at different dose amount

This description comes directly from the study's public registry record.

Talk to the study team

US GSK Clinical Trials Call Center · 877-379-3718 · GSKClinicalSupportHD@gsk.com

EU GSK Clinical Trials Call Center · +44 (0) 20 89904466 · GSKClinicalSupportHD@gsk.com

Always discuss trial participation with your own doctor first.

Locations (65)

GSK Investigational Site	Birmingham, Alabama, United States	Recruiting
GSK Investigational Site	Fountain Valley, California, United States	Recruiting
GSK Investigational Site	Santa Rosa, California, United States	Recruiting
GSK Investigational Site	Lake Mary, Florida, United States	Completed
GSK Investigational Site	Orlando, Florida, United States	Recruiting
GSK Investigational Site	Fairway, Kansas, United States	Recruiting
GSK Investigational Site	Boston, Massachusetts, United States	Recruiting
GSK Investigational Site	Boston, Massachusetts, United States	Recruiting
GSK Investigational Site	Detroit, Michigan, United States	Recruiting
GSK Investigational Site	Grand Rapids, Michigan, United States	Recruiting
GSK Investigational Site	Minneapolis, Minnesota, United States	Recruiting
GSK Investigational Site	Mineola, New York, United States	Recruiting

+ 53 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06431594